Study Detects Benefits From Effective Breast Self Examination

October 31, 1997

Three important components of breast self examination (BSE) appear to be associated with a reduced risk of dying from breast cancer, according to results of a study published in the Nov. 1 issue of The Canadian Medical Association Journal.

"Although we're far from conclusively knowing if there is a benefit to BSE, the results of our study suggest performing specific components of BSE may lower a woman's risk of dying from breast cancer," says the study's principal investigator, Dr. Bart Harvey, an assistant professor in the department of public health sciences at the University of Toronto and associate medical officer of health in East York.

Three components of BSE appear to be associated with a reduced risk of dying from breast cancer: visually examining the breast, using the finger pads to examine the breast and using three middle fingers to examine the breast.

Women who left out one of these components in their BSE technique were almost twice as likely to die from breast cancer or to have distant metastatic disease compared to women who included all three components. Leaving out two of the three components more than doubled the odds of dying compared to when all three components were included. Women who left out all three components had almost three times the odds of dying from breast cancer or having distant metastatic disease compared to women who performed all three. The results were statistically significant and remained unchanged after adjustment for potential confounders, such as a family history of breast cancer.

Using prospectively collected data, the investigators conducted a case-control study of BSE involving patients in the Canadian National Breast Screening Study (CNBSS) to measure the effect of doing BSE on the risk of death due to breast cancer. The CNBSS is a multi-centre randomized controlled trial of screening for breast cancer that recruited 89,835 volunteers between 1980 and 1985; eligible women were aged 40 to 59 years, with no history of breast cancer, were not pregnant and had not undergone mammography in the 12 months before study entry.

All CNBSS participants completed self-administered questionnaires. At the first screen visit, clinical breast exams were performed and BSE instruction given. Each year, eligible participants returned for rescreening, which involved evaluation of BSE, a clinical breast exam, and further BSE instruction, with half the women also receiving annual mammography.

The researchers looked at the case histories of 220 women who either had died from breast cancer or had distant metastatic disease. Eligible subjects for the case-control study were all CNBSS participants except those diagnosed with breast cancer before their second year in the CNBSS, to eliminate the influence of pre-existing cancer. Ten randomly-selected controls were appropriately matched to each case.

To evaluate BSE performance the clinical examiner evaluated eight BSE components: (1) whether the participant included a visual examination; (2) how many fingers she used, did she use her thumb; (3) did she use the tips or pads of her fingers, did she use her entire hand; (4) was her search pattern concentric circles, spokes of a wheel pattern or random; (5) did she press down with a circular motion; (6) did she examine most or only part of her breasts; (7) did she examine her armpits; and (8) how often did she perform BSE.

"While we do need more evidence, this study shows that women who are doing BSE will only benefit from BSE if they do it well," says Dr. Cornelia Baines, an associate professor in the department of public health sciences and deputy director of the CNBSS, who was also involved in conducting the study. Harvey says he hopes this study motivates other researchers to collect more data to better determine if BSE is beneficial and, if it is, to document which components of BSE are important.

The study's investigators also included Anthony Miller, a professor emeritus in the department of public health sciences and director of the CNBSS, and Paul Corey, a professor in the department of public health sciences.

Harvey's research was supported by a Health Research Personnel Development Program doctoral fellowship from the Ontario Ministry of Health. Miller was supported in part by a National Health Scientist Award from Health Canada and Baines was supported in part by the National Cancer Institute of Canada.

University of Toronto

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to